Form 8-K - Current report:
SEC Accession No. 0001558370-25-008683
Filing Date
2025-06-17
Accepted
2025-06-17 16:02:37
Documents
14
Period of Report
2025-06-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vreof-20250617x8k.htm   iXBRL 8-K 39817
2 EX-99.1 vreof-20250617xex99d1.htm EX-99.1 11905
3 GRAPHIC vreof-20250617xex99d1001.jpg GRAPHIC 3446
  Complete submission text file 0001558370-25-008683.txt   163947

Data Files

Seq Description Document Type Size
4 EX-101.SCH vreof-20250617.xsd EX-101.SCH 3433
5 EX-101.LAB vreof-20250617_lab.xml EX-101.LAB 14100
6 EX-101.PRE vreof-20250617_pre.xml EX-101.PRE 9279
16 EXTRACTED XBRL INSTANCE DOCUMENT vreof-20250617x8k_htm.xml XML 4300
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Vireo Growth Inc. (Filer) CIK: 0001771706 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56225 | Film No.: 251053266
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)